ReciBioPharm: Enhancing gene therapies through flexible AAV

We sat down with Xiaojun Liu, director of AAV process development at ReciBioPharm, to discuss the growing need for carefully designed platforms to deliver safe and cost-effective AAV therapies to patients at pace.

Related Keywords

, Bio Developments , Pipelines , Emerging Markets , Cell Amp Gene Therapies , Cell And Gene Therapy , Cell Therapy , Gene Therapy , Hav , Aav Platform ,